Company / Shareholders' Equity
Glucose Health, Inc. Shareholders' Equity History
FY2011-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
-$495.4K
FY2016
5-year range
-$495.4K / -$197.8K
FY2012-FY2016
Trend
-27.8%
vs FY2015
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Glucose Health, Inc. reports negative total equity of -$495,447 in FY2016. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-$495,447 in FY2016.
Declined from -$280,552 to -$495,447 over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Glucose Health, Inc.'s shareholders' equity has declined for 3 consecutive years.
- In FY2016, shareholders' equity decreased 27.8% year-over-year.
- Peak shareholders' equity was recorded in FY2013.
Company context
Key Data Points
- Altman Z-Score -169.46 (distress zone, below 1.23 threshold)
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2016 | -$495.4K | -27.8% |
| FY2015 | -$387.8K | -38.2% |
| FY2014 | -$280.6K | -41.9% |
| FY2013 | -$197.8K | +36.2% |
| FY2011 | -$310.1K | - |